AlphaYouJG
Congress trade
Rep. Josh Gottheimer (D-NJ) bought $1K-$15K of Emergent biosolutions, Inc. (EBS) stock
Josh Gottheimer, U.S. Representative (D-NJ), disclosed a purchase of Emergent biosolutions, Inc. (EBS) stock worth $1K-$15K in a STOCK Act filing on Jul 9, 2020.
The trade happened on Jun 15, 2020, 24 days before it was made public.
EBS has moved -91.1% since the trade date, from $71.07 to $6.33 (Oct 2, 2026 close).
- Traded
- Jun 15, 2020
- Disclosed
- Jul 9, 2020
- Filing delay
- 24 days
- Price since
- -91.1%
- Source
- STOCK Act disclosure
Other trades in this disclosure (37)
- BuyAAPL$1K-$15KJul 9, 2020
- SellABEV$1K-$15KJul 9, 2020
- BuyALC$1K-$15KJul 9, 2020
- BuyALC$1K-$15KJul 9, 2020
- SellAMADY$1K-$15KJul 9, 2020
- SellAMADY$1K-$15KJul 9, 2020
- SellBEN$1K-$15KJul 9, 2020
- SellBKNG$1K-$15KJul 9, 2020
- SellCHL$1K-$15KJul 9, 2020
- SellCOST$1K-$15KJul 9, 2020
- SellCRM$1K-$15KJul 9, 2020
- BuyEBS$1K-$15KJul 9, 2020
- SellENTG$1K-$15KJul 9, 2020
- SellEXAS$1K-$15KJul 9, 2020
- SellEXAS$1K-$15KJul 9, 2020
- SellFIS$1K-$15KJul 9, 2020
- BuyFLT$1K-$15KJul 9, 2020
- SellGOOG$1K-$15KJul 9, 2020
- SellGOOG$1K-$15KJul 9, 2020
- SellHD$1K-$15KJul 9, 2020
More EBS insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.